Repros Therapeutics Inc (RPRX)

[io_io]

Sid...<As to the lack of research...>


I think that's down to ethical reasons - randomized cancer trials almost always have an active control - how do you hope to detect a signal then with an under-sized trial ?

Especially when you are also looking closely at optimal dosing strength and toxicity - often complicated by the therapy combination.


ps: I will answer your other post later - I am way behind in RPRX itself.